Centessa Pharmaceuticals (CNTA) Earnings Date, Estimates & Call Transcripts $17.01 -0.52 (-2.97%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$17.47 +0.46 (+2.73%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals Earnings Summary Centessa Pharmaceuticals released Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.38, which missed analysts' consensus estimates of -$0.35 by $0.03. With a trailing EPS of -$1.79, Centessa Pharmaceuticals' earnings are expected to grow next year, from ($1.60) to ($1.50) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.35 Actual EPS (Aug. 12) -$0.38 Missed By -$0.03 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)SEC FilingCNTA Upcoming EarningsCentessa Pharmaceuticals' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Centessa Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Centessa Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCNTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Centessa Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.38-$0.37-$0.38Q2 20252-$0.41-$0.35-$0.38Q3 20252-$0.44-$0.39-$0.42Q4 20252-$0.40-$0.40-$0.40 Centessa Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/12/2025Q2 2025-$0.35-$0.38 -$0.03-$0.38$0.63M-5/12/2025Q1 2025-$0.35-$0.20+$0.15-$0.20--3/24/2025Q4 2024-$0.38-$0.34+$0.04-$0.84--11/12/2024--$0.42-$0.37+$0.05-$0.37--8/13/2024--$0.38-$0.40 -$0.02-$0.40--5/13/2024Q1 2024-$0.41-$0.38+$0.03-$0.38--3/28/2024Q4 2023-$0.44-$0.38+$0.06-$0.38-$6.85M11/13/2023Q3 2023-$0.46-$0.40+$0.06-$0.40-- Centessa Pharmaceuticals Earnings - Frequently Asked Questions When is Centessa Pharmaceuticals' earnings date? Centessa Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on CNTA's earnings history. Did Centessa Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) missed the analysts' consensus estimate of ($0.35) by $0.03 with a reported earnings per share (EPS) of ($0.38). Learn more on analysts' earnings estimate vs. CNTA's actual earnings. How can I view Centessa Pharmaceuticals' earnings report? Centessa Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded annual revenue of $6.85 million. How much profit does Centessa Pharmaceuticals generate each year? Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded net income of -$235.76 million. CNTA has generated -$1.79 earnings per share over the last four quarters. What is Centessa Pharmaceuticals' EPS forecast for next year? Centessa Pharmaceuticals' earnings are expected to grow from ($1.60) per share to ($1.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies VRNA Earnings ELAN Earnings BPMC Earnings ROIV Earnings LEGN Earnings RVMD Earnings RYTM Earnings RNA Earnings NUVL Earnings AXSM Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:CNTA) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access